Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 hours in patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valves Surgery (ASABYVALV)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin (Primary)
- Indications Coronary arteriosclerosis; Thrombosis
- Focus Biomarker; Pharmacokinetics
- Acronyms ASABYVALV
- 22 Sep 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-001488-40).
- 10 Nov 2011 New trial record
- 08 Nov 2011 Biomarkers information updated